Health Canada Code Systems

*Note: Contains "boardcode", recommend viewing on forum. Plain text email will not show corrections properly.

I have some concerns:
1. AIC: The updated description referring to foreign keys of various tables is inappropriate. The current description is better.

2. AIGc: The updated description should read: “Codes for a particular grouping of active ingredients. This is the 5 characters of the active ingredient code group number starting at position 3 and ending at position 7…”

3. AIGn: The updated description should read: “The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIGn is comprised of three portions:…”

4. NPN: The updated description refers to a DIN-HM. Are NPN and DIN-HM considered to be part of the same code system (2.16.840.1.113883.5.1107)? If yes, heading should be updated to NPN/DIN-HM (2.16.840.1.113883.5.1107).

I also want to point out that several years ago (back in the SCWG days), the AIGc and AIGn were rejected as pan-Canadian standards mainly due to the fact that they are (were?) auto-generated numbers with no human review. This may have changed or may no longer be relevant, but I wanted to point it out. We want to ensure that these code systems are managed/governed as code systems should be as much as possible.

Regards,
Marc

We met with Daniel Buijs from Health Canada yesterday to review all of the Health Canada Code Systems - (CCDD, DIN, NPN, AIGn, AIGc, AIC). In the course of that conversation, we received updated information for the Code Systems - mainly updated email addresses, updated descriptions, and links for more information.

On Nov 13, we plan to update the metadata in the OID Registry for these code systems as follows:

CCDD: (2.16.840.1.113883.2.20.6.1)
Current: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications.

Updated description:
The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. More information can be found here: infocentral.infoway-inforoute.ca/en/standards/canadian/ccdd


AIC: (2.16.840.1.113883.5.1103)
Current: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
A code assigned to any component that has medicinal properties, and supplies pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to affect the structure or any function of the body of man or other animals. www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html
Updated description:

Foreign key for the Active Ingredient Table that relates active ingredients to specific products. More information can be found here: www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/read-file-drug-product-database-data-extract.html


AIGc (2.16.840.1.113883.5.1104)
Current: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
Codes for particular grouping of active ingredients. This is the first 5 characters of active ingredient group number. www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html

Updated description:
Codes for particular grouping of active ingredients. This is the 5 characters of the active ingredient code number starting at position 3 and ending at position 7. www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html


AIGn: (2.16.840.1.113883.5.1106)
Currrent: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
Codes for particular collections of active ingredients combined at specific strengths. www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html

Updated description:
The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions:

• the first portion (2 digits) identifies the number of active ingredients
• the second portion(5 digits) identifies the unique groups of active ingredients(s);
• the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of -2% to +10%.

More information can be found here: www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html


DIN: (2.16.840.1.113883.5.1105)
Current: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
A Drug Identification Number (DIN) is a number assigned by Health Canada to a drug product prior to being marketed in Canada. It consists of eight digits (numbers) generated by a computer system in the Submission and Information Policy Division. www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html

Updated description:
A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada.

A DIN uniquely identifies the following product characteristics:
manufacturer;
product name;
active ingredient(s);
strength(s) of active ingredient(s);
pharmaceutical form; and
route of administration.

Note: The number has a leading zero

More information can be found here: www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html

NPN (2.16.840.1.113883.5.1107)
Current: This email address is being protected from spambots. You need JavaScript enabled to view it.
Updated: This email address is being protected from spambots. You need JavaScript enabled to view it.

Current description:
A unique identifier assigned to natural health products that have been issued a product licence by Health Canada. www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php

Updated description:
Natural Product Number (NPN) is an eight digit numerical code assigned to each natural health product approved to be marketed under the Natural Health Products Regulations. A Homeopathic Medicine Number (DIN-HM) is an eight digit numerical code assigned to each homeopathic medicine approved to be marketed under the Natural Health Products Regulations. More information can be found here: www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html